Table 3.
Overall | Hepatocellular Carcinoma Due to Hepatitis B | Hepatocellular Carcinoma Due to Hepatitis C | Hepatocellular Carcinoma Due to Alcohol Use | Hepatocellular Carcinoma Due to NASH | Hepatocellular Carcinoma Due to Other Cause | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Death Cases (95% UI) | ASMR Per 100,000 (95% UI) | Death Cases (95% UI) | ASMR Per 100,000 (95% UI) | Death Cases (95% UI) | ASMR Per 100,000 (95% UI) | Death Cases (95% UI) | ASMR Per 100,000 (95% UI) | Death Cases (95% UI) | ASMR Per 100,000 (95% UI) | Death Cases (95% UI) | ASMR Per 100,000 (95% UI) | |
Both | 94,937.12 (79,884.26, 111,526.73) | 10.75 (9.12. 12.61) | 61,414.52 (50,743.20, 73,121.84) | 6.53 (5.42, 7.76) | 15,268.45 (12,408.43, 18,500.42) | 2.16 (1.77, 2.60) | 7574.50 (5858.01, 9677.17) | 0.87 (0.69, 1.10) | 4128.19 (3292.97, 5067.91) | 0.50 (0.40, 0.61) | 4981.34 (3957.32, 6185.17) | 0.54 (0.43, 0.67) |
Femlae | 26,633.11 (21,349.83, 32,258.36) | 6.33 (5.08, 7.64) | 9890.15 (7689.56, 12,250.70) | 2.18 (1.70, 2.70) | 8905.90 (6905.99, 10,947.11) | 2.38 (1.87, 2.93) | 2659.16 (1975.72, 3432.94) | 0.61 (0.46, 0.78) | 1995.03 (1515.24, 2481.62) | 0.48 (0.36, 0.59) | 2461.60 (1848.28, 3118.74) | 0.54 (0.41, 0.67) |
Male | 68,304.01 (55,234.66, 83,128.05) | 15.19 (12.32, 18.36) | 51,524.37 (41,304.99, 62,899.38) | 10.96 (8.85, 13.33) | 6362.55 (4834.83, 8108.07) | 1.85 (1.46, 2.28) | 4915.34 (3680.40, 3680.40) | 1.15 (0.87, 1.49) | 2133.16 (1636.88, 2744.31) | 0.53 (0.41, 0.67) | 2519.75 (1949.35, 3259.83) | 0.54 (0.42, 0.69) |
UI: uncertainty interval; NASH: Non-alcoholic steatohepatitis; ASMR: age-standardized mortality rate.